The blood and marrow transplant programme at Mississippi's academic medical centre in Jackson, providing accredited stem cell transplantation for blood cancers and blood disorders.
This is a transplant programme inside a university hospital, not a private regenerative medicine clinic, and the difference is important for anyone comparing options. The University of Mississippi Medical Center in Jackson runs the state's academic bone marrow transplant service, and the treatment it provides — haematopoietic stem cell transplantation — is long-established, regulated and evidence-based medicine for a defined set of blood diseases. It is not the same category of treatment as the injection-based therapies offered by private clinics elsewhere in this directory.
The site states that the stem cells used are collected from circulating blood, from bone marrow, and from umbilical cord blood. It names the conditions treated as immune deficiencies, metabolic disorders, sickle cell disease and certain cancers including leukaemia, lymphoma and myeloma. The pages reviewed do not set out the distinction between autologous transplants, where a patient's own cells are returned to them, and allogeneic transplants using a donor's cells, although the programme's affiliation with the National Marrow Donor Program implies that donor transplants are carried out.
The programme's accreditation and scale are described plainly. It has held continuous accreditation from the Foundation for the Accreditation of Cellular Therapy (FACT) since 2002, has been designated at Center of Excellence level by the Optum Transplant Network, and is affiliated with the National Marrow Donor Program. The site says the programme began in 1992 with four transplants and has since performed more than 1,000 blood and marrow stem cell transplants. Its collection, processing and storage centre is described as registered with the United States Food and Drug Administration as well as FACT-accredited.
No physicians are named on the pages reviewed, and the site publishes nothing about costs. Transplantation for these diagnoses is normally covered by insurance in the United States, and an academic centre of this kind would ordinarily have financial counselling available, but the pages reviewed do not state this, so a patient or family would need to ask.
The conditions named are blood cancers and blood and immune disorders for which transplantation is established treatment.
The site states that the programme uses haematopoietic (blood-forming) stem cells collected from circulating blood, from bone marrow and from umbilical cord blood.
The site describes the programme rather than naming individual clinicians.
The transplant unit is housed in the Conerly Critical Care Hospital on the University of Mississippi Medical Center campus in Jackson, and is described as a twelve-bed inpatient unit. The campus also holds a stem cell collection, processing and storage centre, which the site says is registered with the United States Food and Drug Administration and accredited by the Foundation for the Accreditation of Cellular Therapy. This is a full academic hospital setting with intensive care support, which is a material difference from the outpatient clinics that make up most of this directory.
The pages reviewed publish nothing about cost. Transplantation for the diagnoses listed is ordinarily covered by health insurance in the United States, and the programme's Center of Excellence designation within the Optum Transplant Network reflects insurer contracting, but the site does not set out charges or financial assistance, so a patient would need to ask the hospital directly.
Profile compiled from information published on the clinic's own website and from the StemCell Registry directory record. Details may change; confirm directly with the clinic before making decisions.